Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

JP Morgan Maintains Overweight on Itron, Raises Price Target to $73

JP Morgan analyst Mark Strouse maintains Itron (NASDAQ:ITRI) with a Overweight and raises the price target from $71 to $73.

byBenzinga Newsdesk

July 20, 2022

1 minute read

JP Morgan analyst Mark Strouse maintains Itron (NASDAQ:ITRI) with a Overweight and raises the price target from $71 to $73.

Credit Suisse Initiates Coverage On ChargePoint Hldgs with Outperform Rating, Announces Price Target of $22

By Benzinga Newsdesk

Today, 11:58 AM

Credit Suisse analyst Maheep Mandloi initiates coverage on ChargePoint Hldgs (NYSE:CHPT) with a Outperform rating and announces Price Target of $22.

CHPT

Italian Prime Minister Says Italian Gov’t. Has Approved €14B Of Stimulus Measures, Without Extra Borrowing

By Benzinga Newsdesk

Today, 11:58 AM

-Reuters

EWI

Analyst Ratings

What 10 Analyst Ratings Have To Say About Pfizer

By Benzinga Insights

Today, 11:58 AM

Within the last quarter, Pfizer (NYSE:PFE) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat Bearish…

PFE

Earnings Scheduled For October 7, 2021

By Benzinga Insights

Today, 11:58 AM

Companies Reporting Before The Bell • Lamb Weston Hldgs (NYSE:LW) is estimated to report quarterly earnings at $0.39 per share on revenue of $993.09 million.

ACCD

JP Morgan Maintains Overweight on Itron, Raises Price Target to $73

Related Posts

Credit Suisse Initiates Coverage On ChargePoint Hldgs with Outperform Rating, Announces Price Target of $22

Italian Prime Minister Says Italian Gov’t. Has Approved €14B Of Stimulus Measures, Without Extra Borrowing

What 10 Analyst Ratings Have To Say About Pfizer

Earnings Scheduled For October 7, 2021